Envision Healthcare Holdings Inc. agreed to buy AmSurg Corp., combining two large providers of physicians and other health care services in an all-stock deal with an enterprise value of about $15 billion.
Envision’s investors will own about 53 percent of the combined firm, which will be called Envision Healthcare Corp. The exchange ratio is 0.334 AmSurg shares for each Envision share, the companies said in a statement.
Related: Kaiser moves to acquire Group Health
That values AmSurg at $82.37 a share, or about $4.5 billion, based on Envision’s closing price Wednesday, a premium of about 6.3 percent.
The tax-free transaction will create one of the largest U.S. providers of physicians in specialties including emergency, anesthesia, radiology and children’s services.
AmSurg, which also helps operate ambulatory surgery centers, had tried to combine with another contract-physician company last year, but dropped its bid for Team Health Holdings Inc. after the target company declined to enter merger talks.
Envision Chairman and Chief Executive Officer William Sanger will be executive chairman of the combined firm, while AmSurg CEO Christopher Holden will be the CEO.
Copyright 2018 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
